Janux Therapeutics (JANX) News Today

$48.92
-3.02 (-5.81%)
(As of 08:43 AM ET)
SourceHeadline
marketbeat.com logoJanux Therapeutics (NASDAQ:JANX) Price Target Raised to $63.00 at HC Wainwright
marketbeat.com - May 13 at 8:20 AM
MarketBeat logoCantor Fitzgerald Reiterates "Overweight" Rating for Janux Therapeutics (NASDAQ:JANX)
americanbankingnews.com - May 13 at 5:09 AM
MarketBeat logoQ2 2024 EPS Estimates for Janux Therapeutics, Inc. Raised by Wedbush (NASDAQ:JANX)
americanbankingnews.com - May 13 at 2:16 AM
MarketBeat logoReviewing Lucy Scientific Discovery (NASDAQ:LSDI) and Janux Therapeutics (NASDAQ:JANX)
americanbankingnews.com - May 13 at 1:34 AM
MarketBeat logoQ2 2024 EPS Estimates for Janux Therapeutics, Inc. Cut by Analyst (NASDAQ:JANX)
americanbankingnews.com - May 11 at 2:13 AM
marketbeat.com logoQ2 2024 EPS Estimates for Janux Therapeutics, Inc. Cut by William Blair (NASDAQ:JANX)
marketbeat.com - May 10 at 7:07 AM
MarketBeat logoJanux Therapeutics (NASDAQ:JANX) PT Raised to $74.00 at Wedbush
americanbankingnews.com - May 10 at 5:56 AM
MarketBeat logoJanux Therapeutics, Inc. (NASDAQ:JANX) Given Average Recommendation of "Buy" by Analysts
americanbankingnews.com - May 10 at 4:54 AM
marketbeat.com logoJanux Therapeutics (NASDAQ:JANX) Given "Overweight" Rating at Cantor Fitzgerald
marketbeat.com - May 9 at 11:46 AM
marketbeat.com logoJanux Therapeutics (NASDAQ:JANX) Shares Down 11.5%
marketbeat.com - May 8 at 3:55 PM
benzinga.com logoJanux Therapeutics Options Trading: A Deep Dive into Market Sentiment
benzinga.com - May 8 at 3:46 PM
finance.yahoo.com logoJanux Therapeutics Reports Narrower Q1 Loss, Misses Revenue Estimates
finance.yahoo.com - May 8 at 10:45 AM
businesswire.com logoJanux Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
businesswire.com - May 7 at 4:01 PM
marketbeat.com logoJanux Therapeutics (NASDAQ:JANX) Shares Gap Down to $64.78
marketbeat.com - May 6 at 5:56 PM
msn.com logoJanux Therapeutics gains amid renewed takeover speculation
msn.com - May 2 at 7:10 PM
marketbeat.com logoJanux Therapeutics (NASDAQ:JANX) Sets New 12-Month High at $64.79
marketbeat.com - May 2 at 6:56 PM
finance.yahoo.com logoHere's What Could Help Janux Therapeutics (JANX) Maintain Its Recent Price Strength
finance.yahoo.com - April 30 at 3:15 PM
marketbeat.com logoJanux Therapeutics (NASDAQ:JANX) Shares Up 11.7%
marketbeat.com - April 29 at 2:32 PM
marketbeat.com logoAllspring Global Investments Holdings LLC Acquires 25,105 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)
marketbeat.com - April 28 at 4:26 AM
marketbeat.com logoCerity Partners LLC Makes New $654,000 Investment in Janux Therapeutics, Inc. (NASDAQ:JANX)
marketbeat.com - April 24 at 4:43 AM
marketbeat.com logoJanux Therapeutics (NASDAQ:JANX) Shares Down 4.1%
marketbeat.com - April 17 at 2:37 PM
investorplace.com logoTake the Money and Run: 3 Overbought Stocks to Sell ASAP
investorplace.com - April 17 at 1:12 PM
nasdaq.com logoValidea Detailed Fundamental Analysis - JANX
nasdaq.com - April 17 at 7:35 AM
msn.com logoJonesTrading Initiates Coverage of Janux Therapeutics (JANX) with Buy Recommendation
msn.com - April 16 at 11:00 PM
msn.com logoJanux a new buy at Jones on lead assets for solid tumors
msn.com - April 16 at 6:00 PM
investorplace.com logoThese 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come?
investorplace.com - April 16 at 1:19 PM
benzinga.com logoA Glimpse Into The Expert Outlook On Janux Therapeutics Through 6 Analysts
benzinga.com - April 16 at 1:00 PM
marketbeat.com logoJanux Therapeutics (NASDAQ:JANX) Shares Gap Down to $52.65
marketbeat.com - April 15 at 12:53 PM
fool.com logoWhy Janux Therapeutics Stock Is Crushing It This Week
fool.com - April 12 at 5:40 AM
theglobeandmail.com logoStocks See Continued Pressure as Bond Yields Climb
theglobeandmail.com - April 11 at 12:58 PM
benzinga.com logoWhy Is Cancer-Focused Janux Therapeutics Stock Trading Higher On Thursday?
benzinga.com - April 11 at 12:58 PM
finance.yahoo.com logoBiotech Stocks Heat Up As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options
finance.yahoo.com - April 11 at 12:58 PM
investors.com logoBiotech Stocks Heat Up As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options
investors.com - April 11 at 9:17 AM
fool.com logoWhy Janux Therapeutics Stock Soared as the Market Sagged Today
fool.com - April 10 at 6:39 PM
marketbeat.com logoJanux Therapeutics (NASDAQ:JANX) Sees Unusually-High Trading Volume
marketbeat.com - April 10 at 3:46 PM
msn.com logoJanux Therapeutics surges amid report of takeover interest
msn.com - April 10 at 3:45 PM
marketbeat.com logo
marketbeat.com - April 10 at 1:43 PM
marketbeat.com logoJanux Therapeutics (NASDAQ:JANX) Stock Price Up 6.9%
marketbeat.com - April 8 at 1:45 PM
nasdaq.com logoCommit To Purchase Janux Therapeutics At $25, Earn 26.5% Annualized Using Options
nasdaq.com - April 5 at 5:31 AM
morningstar.com logoJanux Therapeutics Inc Ordinary Shares JANX
morningstar.com - April 5 at 5:31 AM
marketbeat.com logoJanux Therapeutics (NASDAQ:JANX) Shares Down 6.7%
marketbeat.com - April 2 at 4:18 PM
marketbeat.com logoJanux Therapeutics (NASDAQ:JANX) Trading Down 3.3%
marketbeat.com - March 27 at 1:42 PM
marketbeat.com logoJanux Therapeutics, Inc. (NASDAQ:JANX) Given Consensus Rating of "Buy" by Analysts
marketbeat.com - March 21 at 9:12 AM
marketbeat.com logoBTIG Research Begins Coverage on Janux Therapeutics (NASDAQ:JANX)
marketbeat.com - March 21 at 8:21 AM
msn.com logoCantor starts Janux at overweight, cites TCE leadership position
msn.com - March 20 at 5:03 PM
markets.businessinsider.com logoForecasting The Future: 4 Analyst Projections For Janux Therapeutics
markets.businessinsider.com - March 20 at 5:03 PM
finance.yahoo.com logoCancer-Focused Janux Therapeutics Platform Has 'Tremendous Opportunity': Analyst
finance.yahoo.com - March 20 at 5:03 PM
benzinga.com logoCancer-Focused Janux Therapeutics Platform Has 'Tremendous Opportunity': Analyst - Janux Therapeutics (NASDAQ:JANX)
benzinga.com - March 20 at 1:44 PM
marketbeat.com logoJanux Therapeutics (NASDAQ:JANX) Research Coverage Started at Cantor Fitzgerald
marketbeat.com - March 20 at 7:21 AM
marketbeat.com logoJanux Therapeutics (NASDAQ:JANX) Shares Gap Down to $38.81
marketbeat.com - March 19 at 11:53 AM
Get Janux Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for JANX and its competitors with MarketBeat's FREE daily newsletter.

Tech GIANT’s Plans to Revolutionize Crypto… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

JANX Media Mentions By Week

JANX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

JANX
News Sentiment

0.34

0.58

Average
Medical
News Sentiment

JANX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

JANX Articles
This Week

21

2

JANX Articles
Average Week

Get Janux Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for JANX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:JANX) was last updated on 5/13/2024 by MarketBeat.com Staff

From Our Partners